Shares of Celldex Therapeutics (CLDX +4.3%) gain today on the back of positive comments out of...

|About: Celldex Therapeutics, Inc (CLDX)|By:, SA News Editor

Shares of Celldex Therapeutics (CLDX +4.3%) gain today on the back of positive comments out of Cantor, calling the stock one of its top sector picks for 2013. The firm says that company has a solid pipeline, and visibility should to increase this year, mitigating the stock's risk. The firm maintains a Buy rating on the shares, but raises its price target to $13 from $9.